150 related articles for article (PubMed ID: 11238662)
1. Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system.
Croxford JL; Feldmann M; Chernajovsky Y; Baker D
J Immunol; 2001 Mar; 166(6):4124-30. PubMed ID: 11238662
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.
Cua DJ; Hutchins B; LaFace DM; Stohlman SA; Coffman RL
J Immunol; 2001 Jan; 166(1):602-8. PubMed ID: 11123343
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
[TBL] [Abstract][Full Text] [Related]
5. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
Lees JR; Iwakura Y; Russell JH
J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
7. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
[TBL] [Abstract][Full Text] [Related]
9. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
Du C; Sriram S
J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W
Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349
[TBL] [Abstract][Full Text] [Related]
11. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
Juedes AE; Ruddle NH
J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
[TBL] [Abstract][Full Text] [Related]
12. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Gran B; Li J; Siglienti I; Chen X; Calida D; Ventura E; Kamoun M; Rostami A
J Immunol; 2003 Nov; 171(9):4485-92. PubMed ID: 14568921
[TBL] [Abstract][Full Text] [Related]
13. Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats.
Xiao BG; Bai XF; Zhang GX; Link H
J Neuroimmunol; 1998 Apr; 84(2):230-7. PubMed ID: 9628468
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis.
Pagenstecher A; Lassmann S; Carson MJ; Kincaid CL; Stalder AK; Campbell IL
J Immunol; 2000 May; 164(9):4481-92. PubMed ID: 10779748
[TBL] [Abstract][Full Text] [Related]
15. Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis.
Djerbi M; Abdul-Majid KB; Abedi-Valugerdi M; Olsson T; Harris RA; Grandien A
J Immunol; 2003 Feb; 170(4):2064-73. PubMed ID: 12574377
[TBL] [Abstract][Full Text] [Related]
16. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
17. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.
Shaw MK; Lorens JB; Dhawan A; DalCanto R; Tse HY; Tran AB; Bonpane C; Eswaran SL; Brocke S; Sarvetnick N; Steinman L; Nolan GP; Fathman CG
J Exp Med; 1997 May; 185(9):1711-4. PubMed ID: 9151908
[TBL] [Abstract][Full Text] [Related]
18. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
[TBL] [Abstract][Full Text] [Related]
19. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype.
Milovanovic M; Volarevic V; Ljujic B; Radosavljevic G; Jovanovic I; Arsenijevic N; Lukic ML
PLoS One; 2012; 7(9):e45225. PubMed ID: 23028861
[TBL] [Abstract][Full Text] [Related]
20. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.
Carboni S; Aboul-Enein F; Waltzinger C; Killeen N; Lassmann H; Peña-Rossi C
J Neuroimmunol; 2003 Dec; 145(1-2):1-11. PubMed ID: 14644025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
